M. Robinson-rechavi, E. Garcia, H. Laudet, and V. , The nuclear receptor superfamily, Journal of Cell Science, vol.116, issue.4
DOI : 10.1242/jcs.00247

B. Desvergne and W. Wahli, Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism, Endocrine Reviews, vol.20, issue.5, pp.649-688, 1999.
DOI : 10.1210/er.20.5.649

S. Mandard, M. Muller, and S. Kersten, Peroxisome proliferator-activated receptor a target genes, Cellular and Molecular Life Sciences (CMLS), vol.61, issue.4, pp.393-416, 2004.
DOI : 10.1007/s00018-003-3216-3

S. Kersten, S. Mandard, P. Escher, F. Gonzalez, S. Tafuri et al., The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism, The FASEB Journal, vol.15, issue.11, pp.1971-1978, 2001.
DOI : 10.1096/fj.01-0147com

P. Devchand, H. Keller, J. Peters, M. Vazquez, F. Gonzalez et al., The PPAR?????leukotriene B4 pathway to inflammation control, Nature, vol.384, issue.6604, pp.39-43, 1996.
DOI : 10.1038/384039a0

P. Delerive, J. Fruchart, and B. Staels, Peroxisome proliferator-activated receptors in inflammation control, Journal of Endocrinology, vol.169, issue.3, pp.453-459, 2001.
DOI : 10.1677/joe.0.1690453

L. Verme, J. Fu, J. Astarita, G. , L. Rana et al., The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-?? Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide, Molecular Pharmacology, vol.67, issue.1, pp.15-19, 2005.
DOI : 10.1124/mol.104.006353

J. Fruchart, Peroxisome proliferator-activated receptor alpha negatively regulates the Stienstra et al., PPAR? controls the expression of the sIL-1ra in liver vascular inflammatory gene response by negative cross-talk with transcription factors NFkappaB and AP-1, J Biol Chem, vol.274, pp.32048-32054, 1999.

L. Dubuquoy, S. Dharancy, S. Nutten, S. Pettersson, J. Auwerx et al., Role of peroxisome proliferator-activated receptor ?? and retinoid X receptor heterodimer in hepatogastroenterological diseases, The Lancet, vol.360, issue.9343, pp.1410-1418, 2002.
DOI : 10.1016/S0140-6736(02)11395-X

J. Welch, M. Ricote, T. Akiyama, F. Gonzalez, and C. Glass, PPAR?? and PPAR?? negatively regulate specific subsets of lipopolysaccharide and IFN-?? target genes in macrophages, Proceedings of the National Academy of Sciences, vol.100, issue.11, pp.6712-6717, 2003.
DOI : 10.1073/pnas.1031789100

F. Kuipers, M. Jong, Y. Lin, M. Eck, R. Havinga et al., Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes., Journal of Clinical Investigation, vol.100, issue.11, pp.2915-2922, 1997.
DOI : 10.1172/JCI119841

D. Poi, N. Tan, N. Michalik, L. Wahli, W. Desvergne et al., Antiapoptotic Role of PPAR?? in Keratinocytes via Transcriptional Control of the Akt1 Signaling Pathway, Molecular Cell, vol.10, issue.4, pp.721-733, 2002.
DOI : 10.1016/S1097-2765(02)00646-9

A. Lennard, lnterleukin-1 Receptor Antagonist, Critical Reviews??? in Immunology, vol.15, issue.1, pp.77-105, 1995.
DOI : 10.1615/CritRevImmunol.v15.i1.30

C. Butcher, A. Steinkasserer, S. Tejura, and A. Lennard, Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist, J Immunol, vol.153, pp.701-711, 1994.

. Stienstra, PPAR? controls the expression of the sIL-1ra in liver 17

C. Gabay, M. Smith, D. Eidlen, and W. Arend, Interleukin 1 receptor antagonist (IL-1Ra)

C. Orfila, J. Lepert, L. Alric, G. Carrera, M. Beraud et al., Immunohistochemical distribution of activated nuclear factor ??B and peroxisome proliferator-activated receptors in carbon tetrachloride-induced chronic liver injury in rats, Histochemistry and Cell Biology, vol.9, issue.Suppl 3, pp.585-593, 2005.
DOI : 10.1007/s00418-005-0785-2

R. Kleemann, P. Gervois, L. Verschuren, B. Staels, H. Princen et al., Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation, Blood, vol.101, issue.2, pp.545-551, 2003.
DOI : 10.1182/blood-2002-06-1762

C. Gabay, J. Gigley, J. Sipe, W. Arend, and G. Fantuzzi, Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase proteinin vivo, European Journal of Immunology, vol.125, issue.2, pp.490-499, 2001.
DOI : 10.1002/1521-4141(200102)31:2<490::AID-IMMU490>3.0.CO;2-H

C. Gabay, B. Porter, G. Fantuzzi, and W. Arend, Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo, J Immunol, vol.159, pp.5905-5913, 1997.

S. Gregory and E. Wing, Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections, J Leukoc Biol, vol.72, pp.239-248, 2002.

N. Terada, IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner, Gut, vol.47, pp.779-786, 2000.

S. Desiderio and J. Yoo, A Genome-Wide Analysis of the Acute-Phase Response and Its Regulation by Stat3??, Annals of the New York Academy of Sciences, vol.108, issue.1, pp.280-284, 2003.
DOI : 10.1111/j.1749-6632.2003.tb06062.x

. Stienstra, PPAR? controls the expression of the sIL-1ra in liver